MGC Pharma’s (ASX:MXC) first Shipment of CogniCann en route to Australia
- MGC Pharmaceuticals' (MXC) first bulk shipment of CogniCann is en route to Australia and will arrive in the upcoming days
- The first shipment will allow the commencement of the phase IIb clinical trials in partnership with the University of Notre Dame in Western Australia
- The trial will involve 50 patients aged 65 and over, testing the effects of CogniCann on dementia and Alzheimer's patients
MGC Pharma’s first Shipment of CogniCann en route to Australia
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.015(3.80%) |
Mkt cap ! $17.20M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.0¢ | $2.159K | 5.571K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4774 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 44 | 1 |
View Market Depth
| Last trade - 15.37pm 08/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |